https://www.drugpatentwatch.com/p/generic/lisdexamfetamine+dimesylate
Generic LISDEXAMFETAMINE DIMESYLATE INN entry, pharmaceutical patent and freedom to operate
LISDEXAMFETAMINE DIMESYLATE INN patents, expiry and generic drug launch
patent andgenericlisdexamfetamineinnentry
https://pmc.ncbi.nlm.nih.gov/articles/PMC4631394/
New onset executive function difficulties at menopause: a possible role for lisdexamfetamine - PMC
Reports of cognitive decline, particularly in the domains of executive functions (EFs), are common among menopausal women. This study aims to determine the...
executive functionnewonsetdifficultiesmenopause
https://www.droracle.ai/articles/1131888/what-should-be-done-next-when-switching-from-lisdexamfetamine
What should be done next when switching from lisdexamfetamine (Vyvanse) to methylphenidate...
May 5, 2026 - When switching from lisdexamfetamine (Vyvanse) to methylphenidate extended-release (Concerta), you should stop Vyvanse and start Concerta the next morning us...
donenextswitchinglisdexamfetaminevyvanse
https://www.drugsandalcohol.ie/42474/
Lisdexamfetamine in the treatment of methamphetamine dependence: a randomised, placebo-controlled...
Irish drugs and alcohol research, data, policy and sources of evidence on prevention, treatment, rehabilitation, crime and consequences.
the treatmentlisdexamfetaminemethamphetaminedependenceplacebo
https://scholars.duke.edu/publication/1048427
Scholars@Duke publication: Efficacy and safety of lisdexamfetamine dimesylate in adults with...
scholarsdukepublicationefficacysafety
https://discovery.fiu.edu/display/pub78478
Prediction of placebo response in 2 clinical trials of lisdexamfetamine dimesylate for the...
clinical trialsfor thepredictionplaceboresponse
https://www.fda.gov/advisory-committees/pediatric-advisory-committee/vyvanse-capsules-lisdexamfetamine-dimesylate-briefing-materials
Vyvanse Capsules (lisdexamfetamine dimesylate) Briefing Materials | FDA
Briefing materials for the April 12, 2016 meeting of the FDA's Pediatric Advisory Committee
briefing materialsvyvansecapsuleslisdexamfetaminefda
https://thekingsleyclinic.com/resources/lisdexamfetamine-dimesylate-comprehensive-adhd-medication-guide/
Lisdexamfetamine Dimesylate: Comprehensive ADHD Medication Guide - The Kingsley Clinic
Learn about lisdexamfetamine dimesylate (Vyvanse), a leading ADHD medication. Explore its uses, dosages, side effects, and how it compares to Adderall for...
adhd medicationthe kingsleylisdexamfetaminecomprehensiveguide
https://www.pharmac.govt.nz/news-and-resources/consultations-and-decisions/decision-to-fund-lisdexamfetamine-for-the-treatment-of-adhd
Decision to fund lisdexamfetamine for attention deficit hyperactivity disorder (ADHD) - Pharmac |...
decisionfundlisdexamfetamineattentiondeficit
https://digital.library.adelaide.edu.au/items/664e332c-5463-4926-8182-dd8ff7762652
Utilisation trends of lisdexamfetamine: insights from recent medicine shortages in Australia
Purpose: Investigate the impact of recent notified medicine shortages on dispensing patterns of 30, 40, 50, and 60 mg strengths of lisdexamfetamine for...
medicine shortagesutilisationtrendslisdexamfetamineinsights